From Financial Modeling Prep: 2024-10-09 16:00:02

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) faces a potential downside of -31.72%, with analysts lacking confidence in its performance. In contrast, Virios Therapeutics, Inc. (VIRI) shows a potential upside of 13.97%, making it a standout in the biotechnology sector. Virax Biolabs Group Limited (VRAX) has a significant downside, while Unicycive Therapeutics, Inc. (UNCY) offers moderate growth potential.



Read more at Financial Modeling Prep:: Creative Medical Technology Holdings, Inc. (NASDAQ…